Cargando…

New-onset diabetes and antihypertensive treatment

INTRODUCTION: Chronic diseases substantially contribute to the continuous increase in health care expenditures, including type-2 diabetes mellitus as one of the most expensive chronic diseases. Arterial hypertension presents a risk factor for the development of type-2 diabetes mellitus. Numerous ana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grimm, Christine, Köberlein, Juliane, Wiosna, Waldemar, Kresimon, Jutta, Kiencke, Peter, Rychlik, Reinhard
Formato:	Texto
Lenguaje:	English
Publicado:	German Medical Science GMS Publishing House 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3010880/ https://www.ncbi.nlm.nih.gov/pubmed/21289876 http://dx.doi.org/10.3205/hta000081

Ejemplares similares

Monitoring heart functions using telemetry
por: Heinen-Kammerer, Tatjana, et al.
Publicado: (2006)

Antihypertensive therapy, new-onset diabetes, and cardiovascular disease
por: Basile, J N
Publicado: (2009)

Treatment cost of secondary peritonitis in Germany: a comparative study of medical cost incurred for tigecycline therapy and standard regimens
por: Kresimon, J, et al.
Publicado: (2010)

Genome-Wide Association Study Identifies Pharmacogenomic Loci Linked with Specific Antihypertensive Drug Treatment and New-Onset Diabetes
por: Chang, Shin-Wen, et al.
Publicado: (2016)

A Retrospective Longitudinal Cohort Study of Antihypertensive Drug Use and New-Onset Diabetes in Taiwanese Patients
por: Huang, Ching-Ya, et al.
Publicado: (2013)

Assessment of Association between Antihypertensive Drug Use and Occurrence of New-onset Diabetes in South Indian Patients
por: Sabu, Sneha M., et al.
Publicado: (2020)

Hypertension, Antihypertensive Use and the Delayed‐Onset of Huntington's Disease
por: Steventon, Jessica J., et al.
Publicado: (2020)

Hypertension, antihypertensive drugs, and age at onset of Huntington’s disease
por: Zhu, Yahui, et al.
Publicado: (2023)

Alpha Adducin (ADD1) Gene Polymorphism and New Onset of Diabetes Under the Influence of Selective Antihypertensive Therapy in Essential Hypertension
por: Gupta, Sumeet, et al.
Publicado: (2019)

Antihypertensive and Lipid-Lowering Medication Adherence in Young Adults With Youth-Onset Type 2 Diabetes
por: Weinstock, Ruth S., et al.
Publicado: (2023)

Comparing six antihypertensive medication classes for preventing new‐onset diabetes mellitus among hypertensive patients: a network meta‐analysis
por: Yang, Yang, et al.
Publicado: (2017)

Postdonation eGFR and New-Onset Antihypertensive Medication Use After Living Kidney Donation
por: Lentine, Krista L., et al.
Publicado: (2019)

Effects of complex interventions in ‘skin cancer prevention and treatment’: protocol for a mixed-method systematic review with qualitative comparative analysis
por: Beifus, Karolina, et al.
Publicado: (2017)

Antihypertensive Drug Use and New-Onset Diabetes in Female Patients with Coronary Artery Disease: A Population-based Longitudinal Cohort Study
por: Liou, Yi-Sheng, et al.
Publicado: (2015)

Angiotensin Converting Enzyme Gene Insertion/Deletion Polymorphism Is Not Responsible for Antihypertensive Therapy Induced New Onset of Type 2 Diabetes in Essential Hypertension
por: Jhawat, Vikas, et al.
Publicado: (2019)

Individualization of Antihypertensive Drug Treatment
por: Mancia, Giuseppe, et al.
Publicado: (2013)

Antihypertensive Treatment and Blood Pressure in Diabetic and Nondiabetic Patients: The lower, the better?
por: Mancia, Giuseppe, et al.
Publicado: (2011)

On the Sustainability of Guideline Implementation
por: Köberlein, Juliane, et al.
Publicado: (2010)

Antihypertensive Treatment in Severe Aortic Stenosis
por: Kang, Tae Soo, et al.
Publicado: (2018)

A prospective evaluation of persistence on antihypertensive treatment with different antihypertensive drugs in clinical practice
por: Veronesi, Maddalena, et al.
Publicado: (2007)

Antihypertensive Treatment in Diabetic Kidney Disease: The Need for a Patient-Centered Approach
por: Bonino, Barbara, et al.
Publicado: (2019)

Efficacy and Tolerability of Antihypertensive Drugs in Diabetic and Nondiabetic Patients
por: Aslam, Maria, et al.
Publicado: (2017)

Deprescribing antihypertensive treatment in nursing home patients and the effect on blood pressure
por: Gulla, Christine, et al.
Publicado: (2018)

Personalized antihypertensive treatment guided by pharmacogenomics in China
por: Xiao, Zhi-Lin, et al.
Publicado: (2022)

Antihypertensive drug treatment changes in the general population: the colaus study
por: Christe, Vanessa, et al.
Publicado: (2014)

Is Pulse Pressure a Predictor of New-Onset Diabetes in High-Risk Hypertensive Patients?: A subanalysis of the Candesartan Antihypertensive Survival Evaluation in Japan (CASE-J) trial
por: Yasuno, Shinji, et al.
Publicado: (2010)

How Effective Is a Late-Onset Antihypertensive Treatment? Studies with Captopril as Monotherapy and in Combination with Nifedipine in Old Spontaneously Hypertensive Rats
por: Hawlitschek, Christina, et al.
Publicado: (2022)

Diabetic Patients’ Medication Underuse, Illness Outcomes, and Beliefs About Antihyperglycemic and Antihypertensive Treatments
por: Aikens, James E., et al.
Publicado: (2009)

Endothelial effects of antihypertensive treatment: focus on irbesartan
por: Negro, Roberto
Publicado: (2008)

Differential Effects of Comorbidity on Antihypertensive and Glucose-Regulating Treatment in Diabetes Mellitus – A Cohort Study
por: Voorham, Jaco, et al.
Publicado: (2012)

Does antihypertensive treatment with renin-angiotensin system inhibitors prevent the development of diabetic kidney disease?
por: Miyazaki, Hiroki, et al.
Publicado: (2015)

Long-term Effects of Antihypertensive Drug Use and New-onset Osteoporotic Fracture in Elderly Patients: A Population-based Longitudinal Cohort Study
por: Chen, Hung-Yi, et al.
Publicado: (2016)

Synthesis and Antihypertensive Screening of New Derivatives of Quinazolines Linked with Isoxazole
por: Rahman, Mujeeb Ur, et al.
Publicado: (2014)

The economic burden of visual impairment and blindness: a systematic review
por: Köberlein, Juliane, et al.
Publicado: (2013)

Factors Influencing the Acceptability, Acceptance, and Adoption of Conversational Agents in Health Care: Integrative Review
por: Wutz, Maximilian, et al.
Publicado: (2023)

Adherence to Antihypertensive Treatment and Associated Factors in Central Ethiopia
por: G/Tsadik, Daniel, et al.
Publicado: (2020)

Effect of Combined Antihypertensive and Lipid-Lowering Therapies on Cognitive Function: A New Treatment Strategy?
por: Kuang, Ze-Min
Publicado: (2020)

Analysis of antihypertensive treatment using real-world Japanese data—the retrospective study of antihypertensives for lowering blood pressure (REAL) study
por: Ohishi, Mitsuru, et al.
Publicado: (2019)

First-line antihypertensive treatment in patients with pre-diabetes: Rationale, design and baseline results of the ADaPT investigation
por: Zidek, Walter, et al.
Publicado: (2008)

Ramipril-based versus diuretic-based antihypertensive primary treatment in patients with pre-diabetes (ADaPT) study
por: Zidek, Walter, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_j50e3f3r769q5cnmargphh5qai